We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Akashi Halts Trial of DMD Candidate Over ‘Life-Threatening’ Health Issues
Akashi Halts Trial of DMD Candidate Over ‘Life-Threatening’ Health Issues
Cambridge, Mass.-based Akashi Therapeutics has suspended a mid-stage clinical study of its HT-100 compound for the treatment of Duchenne muscular dystrophy, after one of its patients experienced “life-threatening health issues.”